4//SEC Filing
Narula Sanjeev 4
Accession 0000950170-25-013670
CIK 0001567514other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:01 PM ET
Size
5.6 KB
Accession
0000950170-25-013670
Insider Transaction Report
Form 4
Narula Sanjeev
Executive Vice President & CFO
Transactions
- Award
Restricted Stock Units
2025-02-03+22,727→ 22,727 total→ Common Stock (22,727 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]On February 3, 2025, the reporting person was granted 22,727 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001820590
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:01 PM ET
- Size
- 5.6 KB